MARKET RADAR
SENSEX     NIFTY      Refresh
GlaxoSmithKline Pharmaceuticals Consolidated Profit & Loss account, GlaxoSmithKline Pharmaceuticals Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Profit & Loss account - GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals
BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 17:00
2003.30
12.55 (0.63%)
VOLUME 4,920
LIVE
NSE
May 28, 17:00
2004.80
9.75 (0.49%)
VOLUME 3,876

Consolidated Profit & Loss account of GlaxoSmithKline Pharmaceuticals

------------------- in Rs. Cr. -------------------
Dec '10 Dec '09 Dec '08 Dec '07 Dec '06
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Sales Turnover 2,204.95 1,960.61 1,796.87 1,755.16 1,716.27
Excise Duty 41.68 40.46 87.98 145.90 144.19
Net Sales 2,163.27 1,920.15 1,708.89 1,609.26 1,572.08
Other Income 73.08 74.71 219.71 221.11 241.84
Stock Adjustments 19.92 32.87 2.21 -19.63 24.90
Total Income 2,256.27 2,027.73 1,930.81 1,810.74 1,838.82
Expenditure
Raw Materials 811.52 739.07 661.31 621.76 660.46
Power & Fuel Cost 26.75 24.66 24.75 20.54 19.23
Employee Cost 241.25 209.71 173.05 151.45 153.87
Other Manufacturing Expenses 59.71 52.44 46.86 43.48 40.63
Selling and Admin Expenses 188.66 141.30 112.52 118.40 138.90
Miscellaneous Expenses 41.42 56.95 46.11 71.01 60.87
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,369.31 1,224.13 1,064.60 1,026.64 1,073.96
Dec '10 Dec '09 Dec '08 Dec '07 Dec '06
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit 813.88 728.89 646.50 562.99 523.02
PBDIT 886.96 803.60 866.21 784.10 764.86
Interest 0.62 0.37 0.53 1.36 1.36
PBDT 886.34 803.23 865.68 782.74 763.50
Depreciation 17.63 16.37 16.34 20.54 20.08
Other Written Off 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 868.71 786.86 849.34 762.20 743.42
Extra-ordinary items 7.93 2.72 0.50 3.26 6.70
PBT (Post Extra-ord Items) 876.64 789.58 849.84 765.46 750.12
Tax 293.35 260.70 238.14 217.92 199.13
Reported Net Profit 560.57 507.86 591.09 547.55 551.00
Minority Interest 0.00 0.00 0.00 0.00 0.00
Share Of P/L Of Associates 0.00 0.00 0.00 0.00 0.00
Net P/L After Minority Interest & Share Of Associates 570.33 497.74 462.37 405.50 360.51
Total Value Addition 557.78 485.05 403.29 404.88 413.50
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Equity Dividend 338.81 254.11 338.81 304.93 262.58
Corporate Dividend Tax 56.27 43.19 57.58 51.82 36.83
Per share data (annualised)
Shares in issue (lakhs) 847.03 847.03 847.03 847.03 847.03
Earning Per Share (Rs) 66.18 59.96 69.78 64.64 65.05
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00
Book Value (Rs) 230.40 210.87 186.01 163.02 142.23
Source : Dion Global Solutions Limited
Quick Links for glaxosmithklinepharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.